Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nature|October 14, 2005
Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cellsTakeshi Fujiwara, Madhavi Bandi, Masayuki Nitta, et al.
British Journal of Haematology|September 29, 2011
Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cellsDharminder Chauhan, Madhavi Bandi, Ajita V Singh, et al.
Blood|September 1, 2010
A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myelomaDharminder Chauhan, Ajita V Singh, Monette Aujay, et al.
British Journal of Haematology|December 1, 2010
PR-924, a selective inhibitor of the immunoproteasome subunit LMP-7, blocks multiple myeloma cell growth both in vitro and in vivoAjita V Singh, Madhavi Bandi, Monette A Aujay, et al.
SLAS Technology|August 2, 2024
A duplexed high-throughput mass spectrometry assay for bifunctional POLB polymerase and lyase activityZachary A Gurard-Levin, Brian McMillan, Douglas A Whittington, et al.
Cancer Cell|October 6, 2009
Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic targetDharminder Chauhan, Ajita V Singh, Mohan Brahmandam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2011
Antimyeloma activity of a multitargeted kinase inhibitor, AT9283, via potent Aurora kinase and STAT3 inhibition either alone or in combination with lenalidomideLoredana Santo, Teru Hideshima, Diana Cirstea, et al.
Blood|April 13, 2010
A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myelomaGüllü Görgün, Elisabetta Calabrese, Teru Hideshima, et al.
Pageof 2